细胞衰老在女性生殖衰老中的作用及衰老治疗干预的潜力
本综述通过检索MEDLINE、PubMed和Google Scholar,纳入2005至2020年发表的182篇英文文献,其中27篇聚焦生殖衰老的潜在衰老疗法,总结细胞衰老在卵巢、子宫和胎盘衰老中的作用,并探讨靶向衰老细胞的干预策略。
要点
- 高龄产妇与卵母细胞数量和质量下降以及子宫和胎盘功能障碍相关。
- 细胞衰老以不可逆生长停滞和促炎分泌表型为特征,是生殖衰老的基本机制。
- 近十年出现靶向衰老细胞的策略,如调节抗炎反应、氧化应激、DNA损伤及线粒体和蛋白质功能障碍。
核心结论
- 衰老是生殖健康的主要决定因素,细胞衰老是可被利用进行干预的基本衰老机制。
- 近十年出现的靶向衰老细胞的策略在女性生殖衰老研究中显示出有希望的未来干预结果。
研究设计与样本
- 本综述检索MEDLINE、PubMed和Google Scholar,纳入2005至2020年发表的182篇英文文献,其中27篇聚焦生殖衰老的潜在衰老疗法。
- 排除标准为包含「男性」和「植物」术语的文献。
主要发现
- 高龄产妇与卵母细胞数量和质量下降以及子宫和胎盘功能障碍相关,导致不孕、妊娠并发症和子代出生缺陷。
- 细胞衰老以不可逆生长停滞和促炎分泌表型为特征。
- 近十年出现多种靶向衰老细胞的策略,如调节抗炎反应、氧化应激、DNA损伤及线粒体和蛋白质功能障碍。
关键数值与推荐
- 在多数经济合作与发展组织国家,女性平均生育年龄超过30岁。
- 在荷兰、澳大利亚、西班牙、芬兰、德国和英国等国,30至34岁女性的生育率高于其他任何年龄组。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Advanced maternal age is associated with decreased oocyte quantity and quality as well as uterine and placental dysfunctions. These changes lead to infertility, pregnancy complications and birth defects in the offspring. As the mean age of giving birth is increasing worldwide, prevention of age-associated infertility and pregnancy complications, along with the more frequent use of ART, become extremely important. Currently, significant research is being conducted to unravel the mechanisms underlying female reproductive aging. Among the potential mechanisms involved, recent evidence has suggested a contributing role for cellular senescence, a cellular state of irreversible growth arrest characterized by a hypersecretory and pro-inflammatory phenotype. Elucidating the role of senescence in female reproductive aging holds the potential for developing novel and less invasive therapeutic measures to prevent or even reverse female reproductive aging and increase offspring wellbeing. OBJECTIVE AND RATIONALE: The review will summarize the positive and negative implications of cellular senescence in the pathophysiology of the female reproductive organs during aging and critically explore the use of novel senotherapeutics aiming to reverse and/or eliminate their detrimental effects. The focus will be on major senescence mechanisms of the ovaries, the uterus, and the placenta, as well as the potential and risks of using senotherapies that have been discovered in recent years. SEARCH METHODS: Data for this review were identified by searches of MEDLINE, PubMed and Google Scholar. References from relevant articles using the search terms 'Cellular Senescence', 'Aging', 'Gestational age', 'Maternal Age', 'Anti-aging', 'Uterus', 'Pregnancy', 'Fertility', 'Infertility', 'Reproduction', 'Implant', 'Senolytic', 'Senostatic', 'Senotherapy' and 'Senotherapeutic' where selected. A total of 182 articles published in English between 2005 and 2020 were included, 27 of which focus on potential senotherapies for reproductive aging. Exclusion criteria were inclusion of the terms 'male' and 'plants'. OUTCOMES: Aging is a major determinant of reproductive wellbeing. Cellular senescence is a basic aging mechanism, which can be exploited for therapeutic interventions. Within the last decade, several new strategies for the development and repurposing of drugs targeting senescent cells have emerged, such as modulators of the anti-inflammatory response, oxidative stress, DNA damage, and mitochondria and protein dysfunctions. Several studies of female reproductive aging and senotherapies have been discussed that show promising results for future interventions. WIDER IMPLICATIONS: In most countries of the Organization for Economic Co-operation and Development, the average age at which women give birth is above 30 years. Currently, in countries such as the Netherlands, Australia, Spain, Finland, Germany and the UK, birth rates among 30- to 34-year-olds are now higher than in any other age groups. This review will provide new knowledge and scientific advancement on the senescence mechanisms during female reproductive aging, and benefit fundamental and clinical scientists and professionals in the areas of reproduction, cancer, immunobiology and fibrosis.
引用
- Secomandi L, Borghesan M, Velarde M, et al. The role of cellular senescence in female reproductive aging and the potential for senotherapeutic interventions. Hum Reprod Update. 2022. PMID: 34918084. doi:10.1093/humupd/dmab038
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。